Wednesday, 27 January 2021

Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis

Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis admin Wed, 01/27/2021 - 16:35

source https://www.pharmatutor.org/pharma-news/2021/orphan-drug-designation-granted-to-rezafungin-in-eu-for-the-treatment-of-invasive-candidiasis
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...